Mariano Matarranz

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)

Sergio Serrano‐Villar, María Lagarde, Jorge F. Vázquez‐Castellanos et al. · Clinical Infectious Diseases · 2018 · 61 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus–Infected Patients With Nonalcoholic Fatty Liver Disease

Juan Macı́as, M.J. Mancebo, Dolores Merino et al. · Clinical Infectious Diseases · 2017 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

Juan Berenguer, Antonio Rivero, Inmaculada Jarrín et al. · Open Forum Infectious Diseases · 2016 · 42 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +15

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

María Rosa López‐Huertas, Claudia Palladino, Marta Garrido-Arquero et al. · Scientific Reports · 2019 · 34 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16